[Experience in the use of viferon suppositories in young children with juvenile respiratory papillomatosis (preliminary report)].
The authors tried a new medical form of interferon, rectal suppositories viferon, to treat severe juvenile respiratory papillomatosis in young children. Side effects were absent, antibodies to interferon in low titers were registered in 2 patients only. Further studies are needed to specify the promising effects of the above treatment.
Onufrieva
E K
EK
Malinovskaia
V V
VV
Maslova
I V
IV
Nurmukhametov
R Kh
RKh
Kol'tsov
V D
VD
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000906:Antibodies / Q000032:analysis; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007370:Interferon Type I / Q000008:administration & dosage*; D007372:Interferons / Q000276:immunology; D007822:Laryngeal Neoplasms / Q000628:therapy*; D008297:Male; D010212:Papilloma / Q000188:drug therapy*; D011994:Recombinant Proteins; D013488:Suppositories; D014134:Tracheal Neoplasms / Q000628:therapy*
D000276:Adjuvants, Immunologic; D000906:Antibodies; D000970:Antineoplastic Agents; D007370:Interferon Type I; D011994:Recombinant Proteins; D013488:Suppositories; D007372:Interferons
Opyt primeneniia viferona v svechakh u deteĭ mladshego vozrasta s iuvenil'nym respiratornym papillomatozom (predvaritel'noe soobshchenie).